180
Participants
Start Date
November 26, 2023
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2025
ShigETEC live, attenuated, oral vaccine
"Vaccine will be delivered orally.~Stage 1:~Adults (18-45 years) will intake the vaccine 3 times 14 days apart in a dose escalating setting with two different doses.~Stage 2:~Children (2-5 years), Toddlers(12-23 months), Younger children (6-11 months) will intake the vaccine 3 times 14 days apart in a dose escalating setting with three different doses."
Placebo
"Placebo will be delivered orally.~Stage 1:~Adults (18-45 years) will intake the placebo 3 times 14 days apart~Stage 2:~Children (2-5 years), Toddlers(12-23 months), Younger children (6-11 months) will intake the placebo 3 times 14 days apart."
RECRUITING
International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b), Dhaka
Lead Sponsor
Eveliqure Biotechnologies GmbH
INDUSTRY